Asian Spectator

The Times Real Estate

.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

  • Written by ACN Newswire - Press Releases

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

SYDNEY & SAN FRANCISCO, Mar 23, 2021 - (ACN Newswire) - TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost at any time, across one or all sites depending on recruitment needs.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

TrialWire, the algorithm powered recruitment platform, launches a Clinical Trial recruitment 'Insurance' plan. (3/2021)

With more than 80% of clinical trials failing to recruit patients on time, 30% of research sites not able to meet enrollment goals, and 10% of sites not able to enroll any patients, StudyBoost offers peace of mind for Clinical Directors and their CROs.

StudyBoost was designed so that sponsors avoid a trial rescue crisis, saving valuable time and money. If a study needs extra patients, StudyBoost can start delivering instantly and at a significantly reduced cost to normal recruitment. There are no project fees and there is a 50% fee reduction for enrolled patient success.

StudyBoost is ideal for sponsors and CROs wanting to avoid extended recruitment stalls while they find a recruitment firm and process engagement documentation which can take weeks. Which means a study has a recruitment booster plan ready to action at any time recruitment slows.

The package is only available from the start of a study. StudyBoost is available via the TrialWire(TM) self-serve portal, at https://www.trial-wire.com/studyboost/.

About TrialWire(TM) - www.trial-wire.com

The TrialWire(TM) Platform is the most secure service, using advanced algorithms to find the right people who are online that might be suitable for studies listed on the Platform. They are invited into the Platform and taken through the AI-Match screener to determine an exact match to a study-site based or remote/virtual.

No account sign-up is required to find and apply for a study. And unlike all other digital recruitment firms, TrialWire(TM) does NOT keep patient details - no databases so no potential privacy breaches. Sponsors are not paying for database building where patients are sent to other studies.

The Platform ingests study data from approved trial registries like ClinicalTrials.Gov. It uses advanced algorithms, SEO, search marketing, social media, respected news sites, and wellness blogs and more to find patient/trial matches. The algorithms find people based on detailed demographic and location profiles.

Key to TrialWire(TM) success is that it finds motivated people who are online actively trying to find out more about their conditions. These people can be connected to a site in under 2 minutes, and demonstrate the highest retention rates. Find out more about TrialWire at: https://www.trial-wire.com.

Contact:Sydney NSW AUS HQ, +61 2 8218 2145Singapore APAC HQ, +65 3159 3427San Francisco USA HQ, +1 415 951 3228E: team@trial-wire.com, www.trial-wire.com

Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Cerita di balik angpao, amplop merah yang diberikan pada perayaan Tahun Baru Imlek

Remi Chow/UnsplashAmplop merah, yang dikenal sebagai hongbao dalam Bahasa Mandarin (di Indonesia diserap menjadi “angpao”)—merupakan tradisi budaya yang dijunjung tinggi di Cina dan ...

Top 6 Agencies in Louisiana Offering SEO Focused Content Solutions

Nowadays, businesses need a strong internet presence. SEO is one of the finest methods for this. SEO boosts the Google rankings of the websites, making them simpler to find. This article discusses t...

Why Water Tanks in Melbourne Are Essential for Sustainable Living

As one of Australia’s most populous cities, Melbourne faces challenges such as fluctuating water supplies, rising utility costs, and growing environmental concerns. One solution that has gained sign...